Landeskrankenanstalten-Betriebsgesellschaft Kabeg — Clinical Trial Site

43 Registered trials

16 Currently recruiting

Organisation

Landeskrankenanstalten-Betriebsgesellschaft Kabeg

Location

Klagenfurt Am Woerthersee, Austria

Identifier

ORG-100029233

Address

Paul-Hackhofer-Strasse 9, Gries, 9400, Austria

Departments

"Zentrum für Interdisziplinäre Schmerztherapie, Onkologie und Palliativmedizin"
104004: Abteilung für Innere Medizin und Hämatologie und internistische Onkologie
Abteilung für Augenheilkunde und Optometrie
Abteilung für Innere Medizin und Pulmologie
Abteilung für Innere Medizin & Gastroenterologie (IMuG)
Abteilung für Innere Medizin und Gastroenterologie
Abteilung für Innere Medizin und Gastroenterologie, Hepatologie, Endokrinologie, Rheumatologie
Abteilung für Innere Medizin und Kardiologie
Abteilung fur Lungenkrankheiten
Abteilung für Neurologie
Abteilung für Nuklearmedizin und Endokrinologie
Abteilung für Pneumologie
Anästhesiologie und Intensivmedizin
Chir. Abteilung
Department for Internal Medicine and Cardiology
Department for Internal Medicine, Gastroenterology, Hepatology, Endocrinology, Rheumatology and Neph
Department of Anesthesiology and Intensive Care
Department of Anesthesiology and Intensive Care Medicine
Department of Ear, Nose and Throat Disease
Department of Internal Medicine
Department of Internal Medicine and Cardiology
Department of Internal Medicine and Oncology
Department of Internal Medicine-Gastroenterology
Department of Internal Medicine, Gastroenterology, Hepatology, Endocrinology, Rheumatology
Department of Internal Medicine,Gastroenterology,Hepatology,Endocrinology,Rheumatologyand Nephrology
Department of Ophthalmology and Optometry
Department of Otorhinolaryngology
Department of Pulmonary Diseases
Department of Pulmonology and Internal Medicine
Dept of Internal Medicine & Gastroenterology, Hepatology, Endocrinology, Rheumatology & Nephrology
Dept. of Gastroentrology, Hepatology, Endocrinology, Rheumatology and Nephrology
Division of Internal Medicine and Gastroenterology
Gastroenterology, Hepatology, Endocrinology, Rheumatology and Nephrology
Hematology and Oncology
Internal Medicine
Internal Medicine & Cardiology
Klinikum Klagenfurt am Woerthersee
NA
Neurologie

Clinical trials at this site (43)

Search interface

Phase 3 trial of VMX-C001 vs usual pharmacological care in patients taking a FXa direct oral anticoagulant who require urgent surgery with o… Pending

2025-521632-12-00 Patients on Factor Xa inhibitor treatment needing an ur 5
DIRECTION Study Pending

2025-524495-39-00 Chronic Rhinosinusitis with Nasal Polyps 6
Phase 3 Study of Revumenib in Combination with Intensive Chemotherapy in Newly Diagnosed NPM1-mutated AML Recruiting

2025-522279-27-00 Newly Diagnosed AML with an NPM1 mutation 5 2026-04-02
Combined Dose-Finding and CV Outcomes Study with CSL300 (Clazakizumab) in Adult Subjects with ESKD Undergoing Dialysis (POSIBIL6ESKD). Recruiting

2022-500273-14-00 Atherosclerotic cardiovascular disease in patients with 10 2023-07-17
Phase 3, Open-label Study of ARV-471 (PF-07850327) vs Fulvestrant in Participants With ER(+)/ HER2(-) Advanced Breast Cancer (VERITAC-2) Recruiting

2022-500544-38-00 Advanced Breast Cancer 5 2023-06-05
A clinical study of MK-1084 and other treatments for lung cancer (MK-1084-007) Recruiting

2024-514500-14-00 Participants with KRAS G12C-Mutant, Advanced or Metasta 5 2025-12-15
Evaluating the Impact of Maridebart Cafraglutide on Cardiovascular Outcomes in Participants with Atherosclerotic Cardiovascular Disease and … Recruiting

2024-516652-18-00 Atherosclerotic cardiovascular disease (ASCVD) and obes 5 2025-10-10
A clinical trial to evaluate efficacy and safety of Xeomin® injections for preventing chronic migraine Recruiting

2024-515682-34-00 Chronic migraine 5 2025-10-06
A clinical trial to evaluate efficacy and safety of Xeomin® injections for preventing episodic migraine Recruiting

2024-515715-22-00 Episodic migraine 5 2025-10-06
BIOmarker driven intensification of cardiovascular RISK factor management in patients with high risk for recurrent cardiovascular EVENTs The… Recruiting

2024-511950-35-00 Acute Myocardial Infarction 5 2025-06-12
A Study Evaluating the Efficacy and Safety of Pegozafermin in Participants With MASH and Fibrosis (ENLIGHTEN-fibrosis) Recruiting

2023-509912-27-00 Metabolic Dysfunction-Associated Steatotic Liver Diseas 5 2024-11-07
Comparison between ABP 234 and Keytruda® (Pembrolizumab) Recruiting

2024-514304-14-00 Advanced or Metastatic Non-squamous Non-Small Cell Lung 1 2024-10-08
A study to discover if ZED1227 can improve continued celiac disease symptoms despite a gluten-free diet Recruiting

2023-506150-21-00 Celiac Disease 4 2024-05-29
Study to learn about the safety of fazirsiran and if it can help people with alpha-1 antitrypsin liver disease with mild liver scarring (fib… Recruiting

2023-504198-19-00 Alpha-1 Antitrypsin Deficiency-Associated Liver Disease 5 2024-04-18
Selatogrel Outcome Study in Suspected Acute Myocardial Infarction Recruiting

2023-505438-85-00 Acute myocardial infarction (AMI) 5 2022-01-12
The ABC-HCC Trial: A Phase IIIb, randomized, multicenter, open-label trial of Atezolizumab plus Bevacizumab versus transarterial Chemoemboli… Recruiting

2024-512953-26-00 intermediate-stage hepatocellular carcinoma 5 2021-07-06
Effect of high-dose vitamin D on 28-day mortality in adult critically ill patients with severe vitamin D deficiency Recruiting

2024-514556-32-00 Adult critically ill patients with severe vitamin D def 5 2017-02-15
A Study Investigating the Efficacy and Safety of Intravitreal Injections of ANX007 in Participants with Dry Age-Related Macular Degeneration… Ended

2024-515022-88-00 Dry Age-Related Macular Degeneration (AMD) with geograp 5 2025-03-03
A study looking at how effective and safe AZD7798 is in people with Crohn's disease Ended

2023-510487-12-00 Crohn's Disease 4 2024-11-29
A Phase 3 Study of Front‑line Platinum Doublet Therapy With Sotorasib Versus Pembrolizumab in PD-L1 Negative KRAS p.G12C Positive Advanced/M… Ended

2022-501863-41-00 Subjects With Stage IV or Advanced Stage IIIB/C Nonsqua 5 2023-11-13
A Randomized Phase 3 Study of Datopotamab Deruxtecan (Dato-DXd) and Pembrolizumab, with or Without Platinum Chemotherapy, in Subjects with N… Ended

2022-500802-16-00 Advanced or Metastatic PD-L1 TPS <50% Non-squamous Non- 5 2023-11-01
A Phase 3 Placebo-controlled Study of Milvexian after an Acute Ischemic Stroke or High-Risk Transient Ischemic Attack Ended

2022-501176-26-00 Acute Ischemic Stroke and High-Risk Transient Ischemic 5 2023-08-04
OCEAN(a)-Outcomes – Olpasiran trials of Cardiovascular Events And LipoproteiN(a) reduction – Outcomes trial Ended

2022-501608-85-00 Cardiovascular disease (atherosclerotic cardiovascular 5 2023-05-09
Study of DS-1062a with or without Pembrolizumab in Advanced or Metastatic Non-small Cell Lung Cancer without Actionable Genomic Alterations Ended

2023-507933-12-00 Advanced or Metastatic Non-small Cell Lung Cancer (NSCL 5 2022-08-18